Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endoscopic thoracic sympathectomy.

J P Johnson1, C Obasi, M S Hahn

  • 1Division of Neurosurgery, University of California, Los Angeles, USA. johnson@surgery.medsch.ucla.edu

Journal of Neurosurgery
|July 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of Na<sub>V</sub>1.7.

Bioorganic & medicinal chemistry letters·2024
Same author

Molecular Pharmacology of Selective Na<sub>V</sub>1.6 and Dual Na<sub>V</sub>1.6/Na<sub>V</sub>1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo.

ACS chemical neuroscience·2024
Same author

One-stage surgical case management of a two-year-old Arabian horse affected by male-pseudo hermaphroditism.

Journal of equine veterinary science·2024
Same author

Expanding the genotype-phenotype spectrum in SCN8A-related disorders.

BMC neurology·2024
Same author

Expanding the genotype-phenotype spectrum in SCN8A-related disorders.

Research square·2023
Same author

Structure-function relationship of new peptides activating human Na<sub>v</sub>1.1.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2023
Same journal

Extent of resection as an independent predictor of survival for patients with glioblastoma as defined by the new WHO 2021 classification.

Journal of neurosurgery·2026
Same journal

Surgical treatment of schwannomas around the tarsal tunnel: a case series of 40 patients and systematic review of the literature.

Journal of neurosurgery·2026
Same journal

Direct targeting for focused ultrasound thalamotomy in the treatment of movement disorders.

Journal of neurosurgery·2026
Same journal

Development and internal validation of the Meningioma Functional Outcome Risk and Counseling Estimator 6 score, a point-based prognostic tool for predicting 6-week functional independence after intracranial meningioma resection.

Journal of neurosurgery·2026
Same journal

Connectional anatomy of the cerebellum: dentate nucleus and cerebellar peduncles from a surgical perspective.

Journal of neurosurgery·2026
Same journal

Press releases in neurosurgery: is scientific accuracy compromised in public reporting of neurosurgery research?

Journal of neurosurgery·2026
See all related articles

Minimally invasive thoracoscopic sympathectomy offers a safe and effective treatment for hyperhidrosis, with reduced morbidity and hospital stays. However, outcomes for pain syndromes were less favorable compared to open surgery.

Area of Science:

  • Thoracic surgery
  • Minimally invasive procedures
  • Neuromodulation

Background:

  • Thoracic sympathectomy is a treatment for hyperhidrosis and pain disorders.
  • Traditional open surgery had high morbidity.
  • Minimally invasive thoracoscopic sympathectomy offers improved visualization and reduced complications.

Purpose of the Study:

  • To evaluate the efficacy and safety of thoracoscopic sympathectomy.
  • To compare outcomes with traditional open surgical techniques.
  • To assess patient satisfaction for different indications.

Main Methods:

  • 112 thoracoscopic sympathectomy procedures were performed in 65 patients.
  • Outcomes, morbidity, hospital stay, and return to activity were recorded.

Related Experiment Videos

  • Patient satisfaction was assessed postoperatively.

    • Main Results:

    • Thoracoscopic sympathectomy showed equivalent outcomes to open surgery.
    • Reduced surgery-related morbidity, hospital stay, and recovery time were observed.
    • Patient satisfaction was high (66-99%), particularly for hyperhidrosis, but lower for pain syndromes.

    Conclusions:

    • Minimally invasive thoracoscopic sympathectomy is effective for sympathetically mediated disorders.
    • The procedure offers reduced morbidity and comparable outcomes to open surgery.
    • Hyperhidrosis treatment is successful, but pain syndrome outcomes are poorer.